2015
1. Egart M, Janković B, Lah N, Ilić I, Srčič S. Nanomechanical properties of selected single pharmaceutical crystals as a predictor of their bulk behaviour. Pharm Res, 2015: 32, 469-481.
2. Pelipenko J, Kocbek P, Kristl J. Critical attributes of nanofibers: preparation, drug loading, and tissue regeneration. Int J Pharm 2015: 484 (1–2) 57-74.
3. Radivojša Matanović M, Grabnar I, Ahlin Grabnar P, Roškar R. Development and validation of a simple and sensitive size-exclusion chromatography method for quantitative determination of heparin in pharmaceuticals. Acta Pharm 2015: 65 (1) 43-52.
4. Pelipenko J, Kocbek P, Kristl J. Nanofiber diameter as a critical parameter affecting skin cell response. Eur J Pharm Sci, 2015: 66, 29-35.
5. Fonteyne M, Correia A, De Plecker S, Vercruysse J, Ilić I, Zhou Q, Vervaet C, Remon JP, Onofre F, Bulone V, De Beer T. Impact of microcrystalline cellulose material attributes: A case study on continuous twin screw granulation. Int J Pharm 2015: 478 (2) 705-717.
6. Aleksovski A, Dreu R, Gašperlin M, Planinšek Odon. Mini-tablets: a contemporary system for oral drug delivery in targeted patient groups. Exp Opinion Drug Del 2015: 12 (1) 65-84.
2014
1. Egart M, Janković B, Lah N, Ilić I, Srčič S. Nanomechanical properties of selected single pharmaceutical crystals as a predictor of their bulk behaviour. Pharm Res, 2014; DOI: 10.1007/s11095-014-1475-3.
2. Bolko K,Berginc K, Trontelj J, Zvonar A, Kristl A, Gašperlin M. A self-microemulsifying drug delivery system to overcome intestinal resveratrol toxicity and presystemic metabolism. J Pharm Sci, 2014; DOI: 10.1002/jps.24114.
3. Vanić Ž, Planinšek O, Škalko-Basnet N, Tho I. Tablets of pre-liposomes govern in situ formation of liposomes: Concept and potential of the novel drug delivery system. Eur J Pharm Biopharm, 2014; DOI: 10.1016/j.ejpb.2014.06.003.
4. Bertoncelj V, Pelipenko J, Kristl J, Jeras M, Cukjati M, Kocbek P. Development and bioevaluation of nanofibers with blood-derived growth factors for dermal wound healing. Eur J Pharm Biopharm, 2014; DOI: 10.1016/j.ejpb.2014.06.001.
5. Nagelj Kovačič N, Pišlar M, Ilić I, Mrhar A, Bogataj M. Influence of the physiological variability of fasted gastric pH and tablet retention time on the variability of in vitro dissolution and simulated plasmaprofiles. Int J Pharm, 2014: 473 (1-2) 552-559.
6. Zupančič Š, Kocbek P, Zariwala MG, Renshaw D, Orlu GM, Elsaid Z, Taylor K, Somavarapu S. Design and development of novel mitochondrial targeted nanocarriers, DQAsomes for curcumin inhalation. Mol Pharm, 2014: 11 (7) 2334–2345.
7. Kukec S, Hudovornik G, Dreu R, Vrečer F. Study of granule growth kinetics during in situ fluid bed melt granulation using in-line FBRM and SFT probes. Drug Dev Ind Pharm, 2014: 40 (7) 952-959.
8. Egart M, Ilić I, Janković B, Lah N, Srčič S. Compaction properties of crystalline pharmaceutical ingredients according to the Walker model and nanomechanical attributes. Int J Pharm, 2014; 472 (1-2) 347-355.
9. Radivojša Matanović M, Kristl J, Ahlin Grabnar P. Thermoresponsive polymers: Insights into decisive hydrogel characteristics, mechanisms of gelation, and promising biomedical applications. Int J Pharm, 2014: 472 (1-2) 262-275.
10. Oman Kadunc N, Šibanc R, Dreu R, Likar B, Tomaževic D. In-line monitoring of pellet coating thickness growth by means of visual imaging. Int J Pharm, 2014: 470 (1-2) 8-14.
11. Aleksić I, Đuriš J, Ilić I, Ibrić S, Paročić J, Srčič S. In silico modeling of in situ fluidized bed melt granulation. Int J Pharm, 2014: 466 (1-2) 21-30.
12. Bolko K, Zvonar A, Gašperlin M. Simulating the digestion of lipid-based drug delivery systems (LBDDS): overview of in vitro lipolysis models. Acta Chim Slov, 2014: 61 (1) 1-10.
13. Nadrah P, Planinšek O, Gaberšček M. Stimulus-responsive mesoporous silica particles. J Mat Sci, 2014: 49 (2) 481-495.
14. Mašić I, Ilić I, Dreu R, Ibrić S, Parojčić J, Srčič S. Melt granulation in fluidized bed: a comparative study of spray-on versus in situ procedure. Drug Dev Ind Pharm, 2014: 40 (1) 23-32.
15. Bolko K, Zvonar A, Gašperlin M. Mixed lipid phase SMEDDS as an innovative approach to enhance resveratrol solubility. Drug Dev Ind Pharm, 2014: 40 (1) 102-109.